SignalKorea

ALTEOGEN SIGNS DEAL WITH NOVARTIS WORTH UP TO 4.4 TLN WON FOR SUBCUTANEOUS FORMULATIONS - YONHAP

Deal size up to 4.4 trillion won with Novartis signals major licensing revenue potential.

What changed

Deal size up to 4.4 trillion won with Novartis signals major licensing revenue potential.

Why it matters

Deal size up to 4.4 trillion won with Novartis signals major licensing revenue potential. — impact context not separately stored; see What changed.

Sources